1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Severe Asthma Treatment Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Oral
  • 1.3.3 lnhaled
  • 1.3.4 lntravenous
  • 1.3.5 Subcutaneous
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Severe Asthma Treatment Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 Children
  • 1.4.3 Adults
  • 1.4.4 Teenagers
• 1.5 Global Severe Asthma Treatment Market Size & Forecast
  • 1.5.1 Global Severe Asthma Treatment Consumption Value (2021 & 2025 & 2032)
  • 1.5.2 Global Severe Asthma Treatment Sales Quantity (2021-2032)
  • 1.5.3 Global Severe Asthma Treatment Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Teva Pharmaceutical
  • 2.1.1 Teva Pharmaceutical Details
  • 2.1.2 Teva Pharmaceutical Major Business
  • 2.1.3 Teva Pharmaceutical Severe Asthma Treatment Product and Services
  • 2.1.4 Teva Pharmaceutical Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Teva Pharmaceutical Recent Developments/Updates
• 2.2 AstraZeneca
  • 2.2.1 AstraZeneca Details
  • 2.2.2 AstraZeneca Major Business
  • 2.2.3 AstraZeneca Severe Asthma Treatment Product and Services
  • 2.2.4 AstraZeneca Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 AstraZeneca Recent Developments/Updates
• 2.3 GlaxoSmithKline
  • 2.3.1 GlaxoSmithKline Details
  • 2.3.2 GlaxoSmithKline Major Business
  • 2.3.3 GlaxoSmithKline Severe Asthma Treatment Product and Services
  • 2.3.4 GlaxoSmithKline Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 GlaxoSmithKline Recent Developments/Updates
• 2.4 Novartis
  • 2.4.1 Novartis Details
  • 2.4.2 Novartis Major Business
  • 2.4.3 Novartis Severe Asthma Treatment Product and Services
  • 2.4.4 Novartis Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 Novartis Recent Developments/Updates
• 2.5 Sanofi
  • 2.5.1 Sanofi Details
  • 2.5.2 Sanofi Major Business
  • 2.5.3 Sanofi Severe Asthma Treatment Product and Services
  • 2.5.4 Sanofi Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.5.5 Sanofi Recent Developments/Updates
• 2.6 Regeneron Pharmaceutical
  • 2.6.1 Regeneron Pharmaceutical Details
  • 2.6.2 Regeneron Pharmaceutical Major Business
  • 2.6.3 Regeneron Pharmaceutical Severe Asthma Treatment Product and Services
  • 2.6.4 Regeneron Pharmaceutical Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.6.5 Regeneron Pharmaceutical Recent Developments/Updates
• 2.7 4D Pharma plc
  • 2.7.1 4D Pharma plc Details
  • 2.7.2 4D Pharma plc Major Business
  • 2.7.3 4D Pharma plc Severe Asthma Treatment Product and Services
  • 2.7.4 4D Pharma plc Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.7.5 4D Pharma plc Recent Developments/Updates
• 2.8 AB Pharma
  • 2.8.1 AB Pharma Details
  • 2.8.2 AB Pharma Major Business
  • 2.8.3 AB Pharma Severe Asthma Treatment Product and Services
  • 2.8.4 AB Pharma Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.8.5 AB Pharma Recent Developments/Updates
• 2.9 Morphosys
  • 2.9.1 Morphosys Details
  • 2.9.2 Morphosys Major Business
  • 2.9.3 Morphosys Severe Asthma Treatment Product and Services
  • 2.9.4 Morphosys Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.9.5 Morphosys Recent Developments/Updates
• 2.10 Roche
  • 2.10.1 Roche Details
  • 2.10.2 Roche Major Business
  • 2.10.3 Roche Severe Asthma Treatment Product and Services
  • 2.10.4 Roche Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.10.5 Roche Recent Developments/Updates
• 2.11 Avalo Therapeutics
  • 2.11.1 Avalo Therapeutics Details
  • 2.11.2 Avalo Therapeutics Major Business
  • 2.11.3 Avalo Therapeutics Severe Asthma Treatment Product and Services
  • 2.11.4 Avalo Therapeutics Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.11.5 Avalo Therapeutics Recent Developments/Updates
• 2.12 Suzhou Connect Biopharmaceuticals
  • 2.12.1 Suzhou Connect Biopharmaceuticals Details
  • 2.12.2 Suzhou Connect Biopharmaceuticals Major Business
  • 2.12.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product and Services
  • 2.12.4 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.12.5 Suzhou Connect Biopharmaceuticals Recent Developments/Updates
• 2.13 Pieris Pharma
  • 2.13.1 Pieris Pharma Details
  • 2.13.2 Pieris Pharma Major Business
  • 2.13.3 Pieris Pharma Severe Asthma Treatment Product and Services
  • 2.13.4 Pieris Pharma Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.13.5 Pieris Pharma Recent Developments/Updates
• 2.14 Biosion
  • 2.14.1 Biosion Details
  • 2.14.2 Biosion Major Business
  • 2.14.3 Biosion Severe Asthma Treatment Product and Services
  • 2.14.4 Biosion Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.14.5 Biosion Recent Developments/Updates

3 Competitive Environment: Severe Asthma Treatment by Manufacturer

• 3.1 Global Severe Asthma Treatment Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Severe Asthma Treatment Revenue by Manufacturer (2021-2026)
• 3.3 Global Severe Asthma Treatment Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Severe Asthma Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Severe Asthma Treatment Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Severe Asthma Treatment Manufacturer Market Share in 2025
• 3.5 Severe Asthma Treatment Market: Overall Company Footprint Analysis
  • 3.5.1 Severe Asthma Treatment Market: Region Footprint
  • 3.5.2 Severe Asthma Treatment Market: Company Product Type Footprint
  • 3.5.3 Severe Asthma Treatment Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Severe Asthma Treatment Market Size by Region
  • 4.1.1 Global Severe Asthma Treatment Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Severe Asthma Treatment Consumption Value by Region (2021-2032)
  • 4.1.3 Global Severe Asthma Treatment Average Price by Region (2021-2032)
• 4.2 North America Severe Asthma Treatment Consumption Value (2021-2032)
• 4.3 Europe Severe Asthma Treatment Consumption Value (2021-2032)
• 4.4 Asia-Pacific Severe Asthma Treatment Consumption Value (2021-2032)
• 4.5 South America Severe Asthma Treatment Consumption Value (2021-2032)
• 4.6 Middle East & Africa Severe Asthma Treatment Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Severe Asthma Treatment Sales Quantity by Type (2021-2032)
• 5.2 Global Severe Asthma Treatment Consumption Value by Type (2021-2032)
• 5.3 Global Severe Asthma Treatment Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Severe Asthma Treatment Sales Quantity by Application (2021-2032)
• 6.2 Global Severe Asthma Treatment Consumption Value by Application (2021-2032)
• 6.3 Global Severe Asthma Treatment Average Price by Application (2021-2032)

7 North America

• 7.1 North America Severe Asthma Treatment Sales Quantity by Type (2021-2032)
• 7.2 North America Severe Asthma Treatment Sales Quantity by Application (2021-2032)
• 7.3 North America Severe Asthma Treatment Market Size by Country
  • 7.3.1 North America Severe Asthma Treatment Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Severe Asthma Treatment Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Severe Asthma Treatment Sales Quantity by Type (2021-2032)
• 8.2 Europe Severe Asthma Treatment Sales Quantity by Application (2021-2032)
• 8.3 Europe Severe Asthma Treatment Market Size by Country
  • 8.3.1 Europe Severe Asthma Treatment Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Severe Asthma Treatment Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Severe Asthma Treatment Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Severe Asthma Treatment Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Severe Asthma Treatment Market Size by Region
  • 9.3.1 Asia-Pacific Severe Asthma Treatment Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Severe Asthma Treatment Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Severe Asthma Treatment Sales Quantity by Type (2021-2032)
• 10.2 South America Severe Asthma Treatment Sales Quantity by Application (2021-2032)
• 10.3 South America Severe Asthma Treatment Market Size by Country
  • 10.3.1 South America Severe Asthma Treatment Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Severe Asthma Treatment Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Severe Asthma Treatment Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Severe Asthma Treatment Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Severe Asthma Treatment Market Size by Country
  • 11.3.1 Middle East & Africa Severe Asthma Treatment Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Severe Asthma Treatment Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Severe Asthma Treatment Market Drivers
• 12.2 Severe Asthma Treatment Market Restraints
• 12.3 Severe Asthma Treatment Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Severe Asthma Treatment and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Severe Asthma Treatment
• 13.3 Severe Asthma Treatment Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Severe Asthma Treatment Typical Distributors
• 14.3 Severe Asthma Treatment Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Severe Asthma Treatment market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Severe Asthma Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Severe Asthma Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Severe Asthma Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Severe Asthma Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Severe Asthma Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Severe Asthma Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Severe Asthma Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Regeneron Pharmaceutical, 4D Pharma plc, AB Pharma, Morphosys, Roche, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Severe Asthma Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral
lnhaled
lntravenous
Subcutaneous
Market segment by Application
Children
Adults
Teenagers
Major players covered
Teva Pharmaceutical
AstraZeneca
GlaxoSmithKline
Novartis
Sanofi
Regeneron Pharmaceutical
4D Pharma plc
AB Pharma
Morphosys
Roche
Avalo Therapeutics
Suzhou Connect Biopharmaceuticals
Pieris Pharma
Biosion
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Severe Asthma Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Severe Asthma Treatment, with price, sales quantity, revenue, and global market share of Severe Asthma Treatment from 2021 to 2026.
Chapter 3, the Severe Asthma Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Severe Asthma Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Severe Asthma Treatment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Severe Asthma Treatment.
Chapter 14 and 15, to describe Severe Asthma Treatment sales channel, distributors, customers, research findings and conclusion.